Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Triamcinolone acetonide effectively treated black hairy tongue.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Fullerenes show potential in skin care but need more safety research.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

Some alternative therapies for vitiligo show promise but need more research.